Somatic mutations in MEN1 are identified in patients with leukaemia treated with a novel chromatin-targeting therapy, and the mechanism by which these mutations mediate therapeutic resistance is characterized.
- Florian Perner
- Eytan M. Stein
- Sheng F. Cai